Selected research
Market Structure
Global Endocrine Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Endocrine Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Endocrine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Endocrine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Endocrine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Endocrine Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Endocrine Testing Service include Hoffmann-La Roche Ltd., Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A. and Immunodiagnostic Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Endocrine Testing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Endocrine Testing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Endocrine Testing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Endocrine Testing Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Endocrine Testing Service Segment by Company
Hoffmann-La Roche Ltd.
Abbott Laboratories
Agilent Technologies
BioMerieux S.A.
Bio-Rad Laboratories, Inc.
Siemens Healthineers
Danaher Corporation
DiaSorin S.p.A.
Immunodiagnostic Systems
Laboratory Corporation of America Holdings
Fujirebio, Inc.
Thermo Fisher Scientific Inc.
Quest Diagnostics
Sysmex Corporation
MP Biomedicals
Ortho Clinical Diagnostics
Meridian Life Science, Inc.
Endocrine Testing Service Segment by Type
Prolactin Testing
Progesterone Testing
Testosterone Testing
Endocrine Testing Service Segment by Application
Hospitals
Clinics
Endocrine Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endocrine Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Endocrine Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endocrine Testing Service industry.
Chapter 3: Detailed analysis of Endocrine Testing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endocrine Testing Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prolactin Testing
- Progesterone Testing
- Testosterone Testing
Applications
- Hospitals
- Clinics
Companies covered
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Agilent Technologies
- BioMerieux S.A.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers
- Danaher Corporation
- DiaSorin S.p.A.
- Immunodiagnostic Systems
- Laboratory Corporation of America Holdings
- Fujirebio, Inc.
- Thermo Fisher Scientific Inc.
- Quest Diagnostics
- Sysmex Corporation
- MP Biomedicals
- Ortho Clinical Diagnostics
- Meridian Life Science, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Endocrine Testing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Prolactin Testing
- 1.2.3 Progesterone Testing
- 1.2.4 Testosterone Testing
- 1.3 Market Analysis by Application
- 1.3.1 Global Endocrine Testing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.4 Global Market Growth Prospects
- 1.5 Global Endocrine Testing Service Growth Trends by Region
- 1.5.1 Global Endocrine Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Endocrine Testing Service Market Size by Region (2021-2026)
- 1.5.3 Endocrine Testing Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Endocrine Testing Service Market Dynamics
- 2.1 Endocrine Testing Service Industry Trends
- 2.2 Endocrine Testing Service Industry Drivers
- 2.3 Endocrine Testing Service Industry Opportunities and Challenges
- 2.4 Endocrine Testing Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Endocrine Testing Service Revenue by Company (2021-2026)
- 3.2 Global Endocrine Testing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Endocrine Testing Service Key Company Head office and Area Served
- 3.4 Global Endocrine Testing Service Company, Product Type & Application
- 3.5 Global Endocrine Testing Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Endocrine Testing Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Endocrine Testing Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Endocrine Testing Service Tier 1, Tier 2, and Tier 3
4 Endocrine Testing Service Market by Type
- 4.1 Global Endocrine Testing Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Endocrine Testing Service Market Size by Type (2021-2032)
- 4.3 Global Endocrine Testing Service Market Size Share by Type (2021-2032)
5 Endocrine Testing Service Market by Application
- 5.1 Global Endocrine Testing Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Endocrine Testing Service Market Size by Application (2021-2032)
- 5.3 Global Endocrine Testing Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Hoffmann-La Roche Ltd.
- 6.1.1 Hoffmann-La Roche Ltd. Company Information
- 6.1.2 Hoffmann-La Roche Ltd. Business Overview
- 6.1.3 Hoffmann-La Roche Ltd. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Hoffmann-La Roche Ltd. Endocrine Testing Service Product Portfolio
- 6.1.5 Hoffmann-La Roche Ltd. Recent Developments
- 6.2 Abbott Laboratories
- 6.2.1 Abbott Laboratories Company Information
- 6.2.2 Abbott Laboratories Business Overview
- 6.2.3 Abbott Laboratories Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Abbott Laboratories Endocrine Testing Service Product Portfolio
- 6.2.5 Abbott Laboratories Recent Developments
- 6.3 Agilent Technologies
- 6.3.1 Agilent Technologies Company Information
- 6.3.2 Agilent Technologies Business Overview
- 6.3.3 Agilent Technologies Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Agilent Technologies Endocrine Testing Service Product Portfolio
- 6.3.5 Agilent Technologies Recent Developments
- 6.4 BioMerieux S.A.
- 6.4.1 BioMerieux S.A. Company Information
- 6.4.2 BioMerieux S.A. Business Overview
- 6.4.3 BioMerieux S.A. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 BioMerieux S.A. Endocrine Testing Service Product Portfolio
- 6.4.5 BioMerieux S.A. Recent Developments
- 6.5 Bio-Rad Laboratories, Inc.
- 6.5.1 Bio-Rad Laboratories, Inc. Company Information
- 6.5.2 Bio-Rad Laboratories, Inc. Business Overview
- 6.5.3 Bio-Rad Laboratories, Inc. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Bio-Rad Laboratories, Inc. Endocrine Testing Service Product Portfolio
- 6.5.5 Bio-Rad Laboratories, Inc. Recent Developments
- 6.6 Siemens Healthineers
- 6.6.1 Siemens Healthineers Company Information
- 6.6.2 Siemens Healthineers Business Overview
- 6.6.3 Siemens Healthineers Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Siemens Healthineers Endocrine Testing Service Product Portfolio
- 6.6.5 Siemens Healthineers Recent Developments
- 6.7 Danaher Corporation
- 6.7.1 Danaher Corporation Company Information
- 6.7.2 Danaher Corporation Business Overview
- 6.7.3 Danaher Corporation Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Danaher Corporation Endocrine Testing Service Product Portfolio
- 6.7.5 Danaher Corporation Recent Developments
- 6.8 DiaSorin S.p.A.
- 6.8.1 DiaSorin S.p.A. Company Information
- 6.8.2 DiaSorin S.p.A. Business Overview
- 6.8.3 DiaSorin S.p.A. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 DiaSorin S.p.A. Endocrine Testing Service Product Portfolio
- 6.8.5 DiaSorin S.p.A. Recent Developments
- 6.9 Immunodiagnostic Systems
- 6.9.1 Immunodiagnostic Systems Company Information
- 6.9.2 Immunodiagnostic Systems Business Overview
- 6.9.3 Immunodiagnostic Systems Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Immunodiagnostic Systems Endocrine Testing Service Product Portfolio
- 6.9.5 Immunodiagnostic Systems Recent Developments
- 6.10 Laboratory Corporation of America Holdings
- 6.10.1 Laboratory Corporation of America Holdings Company Information
- 6.10.2 Laboratory Corporation of America Holdings Business Overview
- 6.10.3 Laboratory Corporation of America Holdings Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Laboratory Corporation of America Holdings Endocrine Testing Service Product Portfolio
- 6.10.5 Laboratory Corporation of America Holdings Recent Developments
- 6.11 Fujirebio, Inc.
- 6.11.1 Fujirebio, Inc. Company Information
- 6.11.2 Fujirebio, Inc. Business Overview
- 6.11.3 Fujirebio, Inc. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Fujirebio, Inc. Endocrine Testing Service Product Portfolio
- 6.11.5 Fujirebio, Inc. Recent Developments
- 6.12 Thermo Fisher Scientific Inc.
- 6.12.1 Thermo Fisher Scientific Inc. Company Information
- 6.12.2 Thermo Fisher Scientific Inc. Business Overview
- 6.12.3 Thermo Fisher Scientific Inc. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Thermo Fisher Scientific Inc. Endocrine Testing Service Product Portfolio
- 6.12.5 Thermo Fisher Scientific Inc. Recent Developments
- 6.13 Quest Diagnostics
- 6.13.1 Quest Diagnostics Company Information
- 6.13.2 Quest Diagnostics Business Overview
- 6.13.3 Quest Diagnostics Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Quest Diagnostics Endocrine Testing Service Product Portfolio
- 6.13.5 Quest Diagnostics Recent Developments
- 6.14 Sysmex Corporation
- 6.14.1 Sysmex Corporation Company Information
- 6.14.2 Sysmex Corporation Business Overview
- 6.14.3 Sysmex Corporation Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Sysmex Corporation Endocrine Testing Service Product Portfolio
- 6.14.5 Sysmex Corporation Recent Developments
- 6.15 MP Biomedicals
- 6.15.1 MP Biomedicals Company Information
- 6.15.2 MP Biomedicals Business Overview
- 6.15.3 MP Biomedicals Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 MP Biomedicals Endocrine Testing Service Product Portfolio
- 6.15.5 MP Biomedicals Recent Developments
- 6.16 Ortho Clinical Diagnostics
- 6.16.1 Ortho Clinical Diagnostics Company Information
- 6.16.2 Ortho Clinical Diagnostics Business Overview
- 6.16.3 Ortho Clinical Diagnostics Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Ortho Clinical Diagnostics Endocrine Testing Service Product Portfolio
- 6.16.5 Ortho Clinical Diagnostics Recent Developments
- 6.17 Meridian Life Science, Inc.
- 6.17.1 Meridian Life Science, Inc. Company Information
- 6.17.2 Meridian Life Science, Inc. Business Overview
- 6.17.3 Meridian Life Science, Inc. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Meridian Life Science, Inc. Endocrine Testing Service Product Portfolio
- 6.17.5 Meridian Life Science, Inc. Recent Developments
7 North America
- 7.1 North America Endocrine Testing Service Market Size (2021-2032)
- 7.2 North America Endocrine Testing Service Market Size by Type
- 7.2.1 North America Endocrine Testing Service Market Size by Type (2021-2026)
- 7.2.2 North America Endocrine Testing Service Market Size by Type (2027-2032)
- 7.2.3 North America Endocrine Testing Service Market Share by Type (2021-2032)
- 7.3 North America Endocrine Testing Service Market Size by Application
- 7.3.1 North America Endocrine Testing Service Market Size by Application (2021-2026)
- 7.3.2 North America Endocrine Testing Service Market Size by Application (2027-2032)
- 7.3.3 North America Endocrine Testing Service Market Share by Application (2021-2032)
- 7.4 North America Endocrine Testing Service Market Size by Country
- 7.4.1 North America Endocrine Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Endocrine Testing Service Market Size by Country (2021-2026)
- 7.4.3 North America Endocrine Testing Service Market Size by Country (2027-2032)
- 7.4.4 North America Endocrine Testing Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Endocrine Testing Service Market Size (2021-2032)
- 8.2 Europe Endocrine Testing Service Market Size by Type
- 8.2.1 Europe Endocrine Testing Service Market Size by Type (2021-2026)
- 8.2.2 Europe Endocrine Testing Service Market Size by Type (2027-2032)
- 8.2.3 Europe Endocrine Testing Service Market Share by Type (2021-2032)
- 8.3 Europe Endocrine Testing Service Market Size by Application
- 8.3.1 Europe Endocrine Testing Service Market Size by Application (2021-2026)
- 8.3.2 Europe Endocrine Testing Service Market Size by Application (2027-2032)
- 8.3.3 Europe Endocrine Testing Service Market Share by Application (2021-2032)
- 8.4 Europe Endocrine Testing Service Market Size by Country
- 8.4.1 Europe Endocrine Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Endocrine Testing Service Market Size by Country (2021-2026)
- 8.4.3 Europe Endocrine Testing Service Market Size by Country (2027-2032)
- 8.4.4 Europe Endocrine Testing Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Endocrine Testing Service Market Size (2021-2032)
- 9.2 China Endocrine Testing Service Market Size by Type
- 9.2.1 China Endocrine Testing Service Market Size by Type (2021-2026)
- 9.2.2 China Endocrine Testing Service Market Size by Type (2027-2032)
- 9.2.3 China Endocrine Testing Service Market Share by Type (2021-2032)
- 9.3 China Endocrine Testing Service Market Size by Application
- 9.3.1 China Endocrine Testing Service Market Size by Application (2021-2026)
- 9.3.2 China Endocrine Testing Service Market Size by Application (2027-2032)
- 9.3.3 China Endocrine Testing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Endocrine Testing Service Market Size (2021-2032)
- 10.2 Asia Endocrine Testing Service Market Size by Type
- 10.2.1 Asia Endocrine Testing Service Market Size by Type (2021-2026)
- 10.2.2 Asia Endocrine Testing Service Market Size by Type (2027-2032)
- 10.2.3 Asia Endocrine Testing Service Market Share by Type (2021-2032)
- 10.3 Asia Endocrine Testing Service Market Size by Application
- 10.3.1 Asia Endocrine Testing Service Market Size by Application (2021-2026)
- 10.3.2 Asia Endocrine Testing Service Market Size by Application (2027-2032)
- 10.3.3 Asia Endocrine Testing Service Market Share by Application (2021-2032)
- 10.4 Asia Endocrine Testing Service Market Size by Country
- 10.4.1 Asia Endocrine Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Endocrine Testing Service Market Size by Country (2021-2026)
- 10.4.3 Asia Endocrine Testing Service Market Size by Country (2027-2032)
- 10.4.4 Asia Endocrine Testing Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Endocrine Testing Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Endocrine Testing Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Endocrine Testing Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Endocrine Testing Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Endocrine Testing Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Endocrine Testing Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Endocrine Testing Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Endocrine Testing Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Endocrine Testing Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Endocrine Testing Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Endocrine Testing Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Endocrine Testing Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Endocrine Testing Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Endocrine Testing Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst